ArticleAnnals of the rheumatic diseases2022

Response to: 'Tapering antirheumatic drugs in a resource-poor setting: real-world evidence' by Haroon

Elise van Mulligen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.